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Abstract
Introduction: Langerhans' cell histiocytosis is a proliferative histiocytic disorder of unknown
cause originating from dendritic cells.
Case presentation: The authors report a case of Langerhans' cell histiocytosis in a 48-year-old
man with multisystemic disease presentation, including liver involvement.
Conclusion: Hepatic involvement is an uncommon feature in this rare disease and there is no
consensus on the most effective therapeutic approach.
Introduction
Langerhans' cell histiocytosis (LCH) belongs to a group of
disorders where the common primary event is the accu-
mulation and infiltration of monocytes, macrophages,
and dendritic cells into the affected tissues. Its clinical
presentation varies greatly, with symptoms ranging from
mild to severe. The pathophysiology of LCH is not well
understood and an optimal therapeutic strategy has yet to
be established.
Case presentation
A 48-year-old man was referred to our emergency room
with a 10-day history of progressive dyspnea, non-produc-
tive cough and fever. He had previously visited his pri-
mary physician, who prescribed a 7-day treatment with an
antibiotic. The patient had a 34-pack-year history of ciga-
rette smoking, did not take any regular medications and
had not recently visited any tropical country. Physical
examination revealed hyperthermia (38.0°C), with blood
pressure and pulse within normal ranges. He was slightly
polypneic (28 cycles per minute) but had no other sign of
respiratory difficulty. Respiratory sounds were diminished
on both pulmonary bases and no adventitial sounds were
heard. No rash or lymphadenopathy was noted and the
remainder of his physical examination was normal. Room
air arterial blood gas (ABG) was unremarkable and labo-
ratory findings showed slight normocytic normochromic
anemia (hemoglobin (Hb) 12.3 g/dL, hematocrit (Hct)
36.1%), leukocytosis (20,920/mm3), relative neu-
trophilia (75.5%), thrombocytosis (499,000/mm3) and
elevated C-reactive protein (155.9 mg/L). Ionogram and
renal function were normal. Chest X-ray revealed a mild
reduction in lung volume and a mild and diffuse coarse
reticular pattern on both lungs. The patient was diagnosed
with community-acquired pneumonia, and, following
admission to the Medicine ward, was started on empiric
antibiotic therapy with levofloxacin.
During the first days after admission, persistent fever and
high levels of inflammatory markers were noted. Given
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the patient's condition, an investigative diagnostic proce-
dure was initiated. Blood cultures, HIV and hepatitis test-
ing were negative. Coagulation, hepatic function and
urine sediment were unremarkable. Bronchofibroscopy
and bronchoalveolar lavage were negative for malignant
cells, and virologic, bacterial, and mycological examina-
tions and polymerase chain reaction were negative for
mycobacterial DNA. Transthoracic echocardiography
showed no evidence of any valvular vegetation, and a
blood smear was not compatible with any myelodysplas-
tic syndrome. Thoracoabdominal-pelvic computed tom-
ography (CT) scan revealed several lymph nodes in all
mediastinal compartments but no hilar adenomegalies.
Multiple cysts and nodules, with mid to upper zone pre-
dominance, and interstitial thickening were observed in
the lungs (Figure 1). The dimensions of the liver were
enlarged, with several irregular hypoattenuating lesions
and infracentimetric lymph nodes in the hepatic hilum
(Figure 2). As a result, an ultrasound-guided liver biopsy
was performed. Histologic (Figure 3) and immunohisto-
chemical examination (i.e. positivity for S-100 protein
and CD1a antigens) established a diagnosis of LCH.
A course of steroids (prednisolone, 1.0 mg/kg/day) was
initiated, and the patient was encouraged to discontinue
smoking immediately, which clearly improved the clinical
course of the disease. Six months later, he remains asymp-
tomatic, with low levels of inflammatory markers,
although his lung and liver radiological patterns remain
unchanged.
Discussion
LCH is a proliferative histiocytic disorder of unknown
cause originating from dendritic cells [1], with an esti-
Thoracoabdominal-pelvic computed tomography scan of the  patient, showing multiple cysts and nodules and interstitial  thickening in the lungs Figure 1
Thoracoabdominal-pelvic computed tomography scan of the 
patient, showing multiple cysts and nodules and interstitial 
thickening in the lungs.
Thoracoabdominal-pelvic computed tomography scan show- ing several infracentimetric lymph nodes in the hepatic hilum Figure 2
Thoracoabdominal-pelvic computed tomography scan show-
ing several infracentimetric lymph nodes in the hepatic hilum.
Histologic examination of a liver biopsy specimen Figure 3
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mated incidence of one to two cases per million popula-
tion [2]. The disease most commonly occurs in
individuals aged 21 to 69 years, with a mean age of 32
years [3]. From the number of involved organs, patients
can be divided into two categories: those with isolated
skin, lymph node, or bone lesions, and those with a dis-
seminated form of LCH involving two or more organ sys-
tems, such as the lungs, liver and spleen [4]. Treatment of
patients with LCH depends on the extent of the disease.
Steroids may help to slow or even stop the progression of
lung LCH and cessation of smoking is essential to prevent
disease recurrence or progression [5]. Chemotherapeutic
agents, such as vinblastine, methotrexate, cyclophospha-
mide, etoposide, and cladribine have been successful in
patients with progressive disease unresponsive to corticos-
teroids and in those with multiorgan involvement [6].
Nevertheless, no systematic series of treatments for adults
have been published and the optimal strategy has yet to
be defined. In the case described here, however, steroid
therapy plus the cessation of smoking improved the gen-
eral condition of the patient.
Conclusion
LCH is a rare disease with multiple clinical features, such
that only histologic examination and immunohistochem-
ical assays can lead to a final diagnosis. Smoking cessation
and steroid therapy can improve the clinical course in
patients with LCH and multisystem involvement. There is
as yet no consensus on the ideal therapeutic regimen and
management approach.
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